Meeting
2022 ASCO Gastrointestinal Cancers Symposium
Pancreatic cancer detection using 5-hydroxymethylation signatures in plasma-derived cell free DNA in high-risk patients with new onset diabetes.
Authors
David Haan
Bluestar Genomics, San Diego, CA
David Haan , Gulfem Guler , Anna Bergamaschi , Wayne Volkmuth , Samuel Levy
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer
Sub Track
Prevention, Screening, and Hereditary Cancers
DOI
10.1200/JCO.2022.40.4_suppl.539
Abstract #
539
Poster Bd #
F8
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Early detection of pancreatic cancer using 5-hydroxymethylation profiles in plasma-derived cell-free DNA.
First Author: Anna Bergamaschi
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Enhanced blood-based colorectal cancer screening with improved performance in detection of early stage disease.
First Author: Sven Duenwald
Poster
2023 ASCO Annual Meeting
Detecting early stage breast cancer using low-depth cell-free DNA fragmentomics: A multi-center cohort study.
First Author: Jiaqi Liu
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Early detection and localization of major gastrointestinal cancers by combining DNA methylation and fragmentomic signatures generated from a single cfDNA targeted sequencing assay.
First Author: Xinrong Yang